NEW DELHI – India is taking a series of steps to power its biopharmaceutical industry that could lead to more investment, better infrastructure for drug development and a visible reduction in red tape. One of the more significant such steps is the development of a series of biotech and pharmaceutical industry clusters that could help speed up drug discovery and development.